Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.

A 20-kD homologous restriction factor (HRF20) which is a membrane inhibitor of the terminal stage of human complement action can be detected by the monoclonal antibody 1F5, and is deficient on abnormal erythrocytes as well as leucocytes from patients with paroxysmal nocturnal haemoglobinuria (PNH)....

Full description

Saved in:
Bibliographic Details
Main Authors: Okada, N, Harada, R, Okada, H
Format: Artigo
Language:Inglês
Published: 1990
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1535229/
https://ncbi.nlm.nih.gov/pubmed/1691059
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items